Eyestem announces completion of phase one of its RPE Cell Therapy The trial evaluates the safety and efficacy of Eyecyte-RPE in patients with geographic atrophy secondary to dry age-related…
Eyestem raises funds from global investors in Switzerland, South Africa The investment will boost Eyestem's efforts to find treatment for dry age-related macular degeneration, leading cause of incurable…
